Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients : Results from a real-life patient cohort.
Karolyi M, Pawelka E, Mader T, Omid S, Kelani H, Ely S, Jilma B, Baumgartner S, Laferl H, Ott C, Traugott M, Turner M, Seitz T, Wenisch C, Zoufaly A. Karolyi M, et al. Among authors: ely s. Wien Klin Wochenschr. 2021 Apr;133(7-8):284-291. doi: 10.1007/s00508-020-01720-y. Epub 2020 Aug 10. Wien Klin Wochenschr. 2021. PMID: 32776298 Free PMC article.
COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria.
Pawelka E, Karolyi M, Mader T, Omid S, Kelani H, Baumgartner S, Ely S, Hoepler W, Jilma B, Koenig F, Laferl H, Traugott M, Turner M, Seitz T, Wenisch C, Zoufaly A. Pawelka E, et al. Among authors: ely s. Infection. 2021 Oct;49(5):907-916. doi: 10.1007/s15010-021-01610-z. Epub 2021 May 13. Infection. 2021. PMID: 33983624 Free PMC article.
Correction to: COVID-19 is not "just another flu": a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria.
Pawelka E, Karolyi M, Mader T, Omid S, Kelani H, Baumgartner S, Ely S, Hoepler W, Jilma B, Koenig F, Laferl H, Traugott M, Turner M, Seitz T, Wenisch C, Zoufaly A. Pawelka E, et al. Among authors: ely s. Infection. 2021 Oct;49(5):917. doi: 10.1007/s15010-021-01654-1. Infection. 2021. PMID: 34287791 Free PMC article. No abstract available.
Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism.
Mühlbacher J, Schörgenhofer C, Doberer K, Dürr M, Budde K, Eskandary F, Mayer KA, Schranz S, Ely S, Reiter B, Chong E, Adler SH, Jilma B, Böhmig GA. Mühlbacher J, et al. Among authors: ely s. Transpl Int. 2021 Aug;34(8):1542-1552. doi: 10.1111/tri.13954. Epub 2021 Jul 8. Transpl Int. 2021. PMID: 34153143 Free PMC article. Clinical Trial.
Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial.
Mayer KA, Budde K, Halloran PF, Doberer K, Rostaing L, Eskandary F, Christamentl A, Wahrmann M, Regele H, Schranz S, Ely S, Firbas C, Schörgenhofer C, Kainz A, Loupy A, Härtle S, Boxhammer R, Jilma B, Böhmig GA. Mayer KA, et al. Among authors: ely s. Trials. 2022 Apr 8;23(1):270. doi: 10.1186/s13063-022-06198-9. Trials. 2022. PMID: 35395951 Free PMC article.
One World, One Health: Tackling the Global Health Crisis.
Haight M, Ausel E, Bahner I, Belovich AN, Brenneman A, Brooks WS, Ely S, Garwood S, Habal S, Hernandez M, Ikonne U, McKell D, Porter R, Rowe R, Taylor TAH, Thesen T. Haight M, et al. Among authors: ely s. Med Sci Educ. 2024 Apr 11;34(3):717-721. doi: 10.1007/s40670-024-02038-4. eCollection 2024 Jun. Med Sci Educ. 2024. PMID: 38887407 No abstract available.
361 results